Literature DB >> 8175675

The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms.

S Immenschuh1, Y Nagae, H Satoh, H Baumann, U Muller-Eberhard.   

Abstract

Hemopexin (Hx) is an abundant acute-phase protein (APP) that binds heme with high affinity. In rat hepatic cells, the transcription rate of the Hx gene is increased by interleukin (IL)-1 and IL-6. To investigate the cis-acting regulatory elements (REs) responsive to these hormones, chloramphenicol acetyltransferase constructs of rat and human Hx gene sequences were tested in transiently transfected hepatoma cells. An IL-6-RE was identified in the promoter of both rat and human Hx genes, the function of which was dependent on the core sequence (CCGGGAA) common in other APP genes. The previously characterized Hx A element mediated a relatively minor cytokine response as compared with the Hx IL-6-RE. The human Hx A element, in contrast to the rat and human Hx IL-6-REs, was strongly trans-activated by cotransfected CAAT enhancer-binding proteins (C/EBP)-beta and -delta. The rat gene homolog of the human Hx A element was inactive as a cytokine RE and was minimally trans-activated by C/EBP isoforms. Results of electrophoretic mobility shift assays indicated that the Hx IL-6-RE is a binding site for the IL-6-inducible nuclear protein IL-6 RE-BP, which also binds to the conserved IL-6-REs of other APP genes and is distinct from C/EBP beta.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175675

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.

Authors:  T Alonzi; D Maritano; B Gorgoni; G Rizzuto; C Libert; V Poli
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.

Authors:  H Kim; T S Hawley; R G Hawley; H Baumann
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

3.  Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.

Authors:  C A Cantwell; E Sterneck; P F Johnson
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

4.  Altered activity of plasma hemopexin in patients with minimal change disease in relapse.

Authors:  Winston W Bakker; Catharina M L van Dael; Leonie J W M Pierik; Joanna A E van Wijk; Jeroen Nauta; Theo Borghuis; Jola J Kapojos
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

5.  Transcriptional activation of the haem oxygenase-1 gene by cGMP via a cAMP response element/activator protein-1 element in primary cultures of rat hepatocytes.

Authors:  S Immenschuh; V Hinke; A Ohlmann; S Gifhorn-Katz; N Katz; K Jungermann; T Kietzmann
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

6.  The role of Stat and C/EBP transcription factors in the synergistic activation of rat serine protease inhibitor-3 gene by interleukin-6 and dexamethasone.

Authors:  T Kordula; J Travis
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

Review 7.  Heme as a Target for Therapeutic Interventions.

Authors:  Stephan Immenschuh; Vijith Vijayan; Sabina Janciauskiene; Faikah Gueler
Journal:  Front Pharmacol       Date:  2017-04-04       Impact factor: 5.810

8.  Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia.

Authors:  Beibei Dong; Min Cai; Zongping Fang; Haidong Wei; Fangyun Zhu; Guochao Li; Hailong Dong; Lize Xiong
Journal:  BMC Neurosci       Date:  2013-06-10       Impact factor: 3.288

Review 9.  TLR4 Signaling by Heme and the Role of Heme-Binding Blood Proteins.

Authors:  Sabina Janciauskiene; Vijith Vijayan; Stephan Immenschuh
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

Review 10.  Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.

Authors:  Francesca Vinchi; Emanuela Tolosano
Journal:  Oxid Med Cell Longev       Date:  2013-05-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.